(Q48446864)

11 February 2018

title

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma (English)

1 reference

11 February 2018

0 references

0 references

1 reference

1 reference

9

Gabriel N Hortobagyi

1 reference

11 February 2018

author name string

Edgardo Rivera

1

1 reference

11 February 2018

Christina Meyers

2

1 reference

11 February 2018

Morris Groves

3

1 reference

11 February 2018

Vicente Valero

4

1 reference

11 February 2018

Deborah Francis

5

1 reference

11 February 2018

Banu Arun

6

1 reference

11 February 2018

Kristine Broglio

7

1 reference

11 February 2018

Guosheng Yin

8

1 reference

11 February 2018

Thomas Buchholz

10

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 2006

1 reference

11 February 2018

published in

Cancer

1 reference

11 February 2018

volume

107

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

1348-1354

1 reference

11 February 2018

Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Brain metastases in patients with breast cancer: new horizons

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

CNS metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Radiation-induced dementia in patients cured of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Response of brain metastases from breast cancer to systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22127

7 January 2021

Identifiers

DOI

10.1002/CNCR.22127

1 reference

11 February 2018

1 reference

11 February 2018